Experimental Daily Pill Doubles Survival for Pancreatic Cancer Patients

An experimental daily pill, daraxonrasib, has been hailed as a breakthrough, demonstrating the ability to double survival times and improve the quality of life for patients with pancreatic cancer, a notoriously deadly form of the disease. Clinical trials indicate a significant breakthrough in treating this previously almost untreatable cancer.

31 May, 12:00 — 1 Jun, 02:50

Post Share

Why this matters

Pancreatic cancer is notoriously aggressive and difficult to treat, with a very low survival rate, making any significant advancement in treatment critically important. These experimental drugs offer new hope for extending life and potentially improving the quality of life for patients facing this deadly disease.

Key entitiesDaraxonrasib Amivantamab Revolution Medicines Pancreatic Cancer

The Story

What 13 sources agree on, dispute, and miss

What sources agree on

An experimental drug significantly extended survival for advanced pancreatic cancer patients in a clinical trial
Pancreatic cancer is one of the deadliest types of cancer
The new treatment offers hope for improved outcomes for patients

Key claims4 agreed · 1 unverified

✓

The drug daraxonrasib is a daily pill.

agreed·BBCstraits-timesThe Guardian

✓

Daraxonrasib doubled the survival time for pancreatic cancer patients.

agreed·BBCstraits-timesThe Guardian

Patients taking daraxonrasib lived for a median of 13.2 months compared to 6.7 months for chemotherapy recipients.

unverified·cnbc

✓

The drug amivantamab is an injectable treatment.

agreed·hvgbalkan-webobservadorstar-malaysia

✓

Amivantamab can eradicate or significantly shrink entire tumors.

agreed·hvgbalkan-webobservadorstar-malaysia

Where they diverge

The specific experimental drug being reported on

BBCDaily Sabahseeking-alphastraits-timesNPR+4 morecnbcYahooAPThe Guardian

Focus on daraxonrasib, a daily pill that doubled survival time

hvgbalkan-webobservadorstar-malaysia

Focus on amivantamab, an injectable drug that can eradicate tumors

The primary outcome measure of the drug's effectiveness

BBCDaily Sabahstraits-timesNPRcnbc+3 moreYahooAPThe Guardian

Doubling of median survival time for patients

hvgbalkan-webobservadorstar-malaysia

Ability to destroy or significantly shrink entire tumors

Coverage gaps

Specific median survival times for daraxonrasib vs. chemotherapy

Reportedcnbc

MissingBBCDaily Sabahseeking-alpha+5

Mention of improved quality of life alongside extended survival

Reportedstraits-times

MissingBBCDaily Sabahseeking-alpha+5

Coverage matrix(13 sources)

1–10 of 13

	AP	BBC	The Guardian	NPR	cnbc	hvg	Yahoo	observador	straits-times	seeking-alpha
The primary outcome measure of the drug's effectiveness
Specific median survival times for daraxonrasib vs. chemotherapy
Mention of improved quality of life alongside extended survival

Covered Divergent Not mentioned

The Story

Analyzing sources…

Source Diversity

Excellent (100/100)

13 sources33/33

Spectrum spread— 5/5 buckets covered33/33

Far L1

Far Left (1)

The Guardian

Left5

Left (5)

BBCNPRcnbcYahoohvg

Center2

Center (2)

APbalkan-web

Right4

Right (4)

seeking-alphastraits-timesobservadorstar-malaysia

Far R1

Far Right (1)

Daily Sabah

Geographic diversity— 8 regions34/34

US5UK2Turkey1Singapore1Hungary1Albania1Portugal1Malaysia1

Political spectrum

LeftCenterRight

guardian

npr

hvg

bbc

cnbc

yahoo

balkan-web

seeking-alpha

straits-times

star-malaysia

observador

daily-sabah

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

The GuardianleftleftoptimisticMostly FactualEmphasizes 'gamechanger' aspect for patients

NPRcenter-leftcenter-leftoptimisticHighFocus on hope for patients with deadly cancer

Coverage leans: center-left

The coverage is largely balanced, focusing on scientific findings, but a slight lean towards center-left is observed due to the prominence of outlets with established center-left biases in reporting on the daraxonrasib breakthrough.

Sources

Showing 9 of 13 sources

APVery High18h ago

Experimental pill promises new hope for deadly pancreatic cancer - AP News

Experimental pill promises new hope for deadly pancreatic cancer AP News

Read full article →

BBCHigh3h ago

Daily pill doubles survival time for pancreatic cancer patients

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.

Read full article →

The GuardianMostly Factual18h ago

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades. Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help. For decades, scientists have worked relentlessly trying to find clever solutions for a fo...

By Andrew Gregory Health editor in Chicago

Read full article →

NPRHigh17h ago

Experimental pill promises new hope for deadly pancreatic cancer

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

By The Associated Press

Read full article →

cnbcMostly Factual17h ago

Experimental pill promises new hope for deadly pancreatic cancer

Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.

Read full article →

YahooMostly Factual18h ago

Experimental pill promises new hope for deadly pancreatic cancer

Read full article →

straits-timesMostly Factual16h ago

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life - The Straits Times

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life The Straits Times

Read full article →

seeking-alphaMixed14h ago

Revolution Medicines reports Phase 3 win in pancreatic cancer

Read full article →

Daily SabahMixed12h ago

Experimental pill offers breakthrough hope in pancreatic cancer fight

An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment against one of the deadlie...

Read full article →

Coverage Timeline

First report: star-malaysia · 31 May, 02:39|Full coverage: 13 · 1d|Window: 1d

Left-leaningCenterRight-leaning

star-malaysia31 May, 02:39First to report

Cancer jabs destroy whole tumours in treatment-resistant cases - The Star

8h later

observador31 May, 10:24

Injeção pode erradicar tumores inteiros em doentes

balkan-web31 May, 10:30

Gati kura kundër kancerit? Tkurrje të tumorit ose regres i dukshëm, çfarë zbuloi studimi i ri

hvg31 May, 10:34

Hatásosnak tűnik egy rák elleni injekció

1h later

The Guardian31 May, 12:00

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life - The Straits Times

2h later

seeking-alpha31 May, 15:33

Revolution Medicines reports Phase 3 win in pancreatic cancer

2h later

Daily Sabah31 May, 17:31

Experimental pill offers breakthrough hope in pancreatic cancer fight

9h later

BBC1 Jun, 02:50Latest update

Daily pill doubles survival time for pancreatic cancer patients

Story evolution

The initial narrative around a tumor-destroying injection shifted to a more prominent narrative about a daily pill doubling survival, indicating two distinct but concurrent medical breakthroughs being reported.

Initial Reports on AmivantamabMay 31 early morning

Early reports, primarily from non-English outlets, focused on an injectable drug, amivantamab, capable of destroying entire tumors.

Widespread Reporting on DaraxonrasibMay 31 late morning - June 1

Later and more widespread coverage, mainly from English-language outlets, highlighted the daily pill daraxonrasib and its ability to double survival time.

Experimental Daily Pill Doubles Survival for Pancreatic Cancer Patients

Why this matters

The Story

What sources agree on

Key claims4 agreed · 1 unverified

Where they diverge

Coverage gaps

Coverage matrix(13 sources)

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

Experimental pill promises new hope for deadly pancreatic cancer - AP News

Daily pill doubles survival time for pancreatic cancer patients

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life - The Straits Times

Revolution Medicines reports Phase 3 win in pancreatic cancer

Experimental pill offers breakthrough hope in pancreatic cancer fight

Coverage Timeline

Cancer jabs destroy whole tumours in treatment-resistant cases - The Star

Injeção pode erradicar tumores inteiros em doentes

Gati kura kundër kancerit? Tkurrje të tumorit ose regres i dukshëm, çfarë zbuloi studimi i ri

Hatásosnak tűnik egy rák elleni injekció

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experimental pill promises new hope for deadly pancreatic cancer - AP News

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life - The Straits Times

Revolution Medicines reports Phase 3 win in pancreatic cancer

Experimental pill offers breakthrough hope in pancreatic cancer fight

Daily pill doubles survival time for pancreatic cancer patients

Story evolution

Related Stories

Extreme Training: What Heat Training Does to the Body

Dangerous Heat Index Forecast for 32 Areas in the Philippines on June 1

Four Fat-Rich Foods to Lower High Blood Pressure

First-ever pig liver and two kidney transplant into human performed in China

Why this matters

The Story

What sources agree on

Key claims4 agreed · 1 unverified

Where they diverge

Coverage gaps

Coverage matrix(13 sources)

Story evolution

Political spectrum